trending Market Intelligence /marketintelligence/en/news-insights/trending/2yzaq2t9yd_vntdoqyktta2 content esgSubNav
In This List

Avid Bioservices CFO resigns

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Avid Bioservices CFO resigns

Paul Lytle is voluntarily resigning as CFO of Avid Bioservices Inc.

Lytle's resignation will be effective 90 days from the date of his Feb. 23 notice.

The company is starting a search for its next CFO.

Avid Bioservices is a Tustin, Calif.-based a biopharmaceutical company that researches and develops antibodies for the treatment of cancer in the U.S.